Annick Desjardins

Annick Desjardins

UNVERIFIED PROFILE

Are you Annick Desjardins?   Register this Author

Register author
Annick Desjardins

Annick Desjardins

Publications by authors named "Annick Desjardins"

Are you Annick Desjardins?   Register this Author

100Publications

1522Reads

30Profile Views

Second primary cancers in long-term survivors of glioblastoma.

Neurooncol Pract 2019 Sep 4;6(5):386-391. Epub 2019 Feb 4.

Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npz001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753354PMC
September 2019

Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population.

Complement Ther Clin Pract 2019 Aug 18;36:43-48. Epub 2019 May 18.

Department of Neurosurgery, The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, DUMC Box 3624, Durham, NC, 27710, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctcp.2019.05.002DOI Listing
August 2019

Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations.

J Immunother Cancer 2019 May 29;7(1):142. Epub 2019 May 29.

Department of Neurosurgery and the Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Medical Sciences Research Building, Rm 181c, Box 3156, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0614-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542114PMC
May 2019

Adjunctive perampanel for glioma-associated epilepsy.

Epilepsy Behav Case Rep 2018 9;10:114-117. Epub 2018 Oct 9.

Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States of America.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22133232183010
Publisher Site
http://dx.doi.org/10.1016/j.ebcr.2018.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202665PMC
October 2018

Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.

J Neurooncol 2018 Jul 21;138(3):489-498. Epub 2018 Mar 21.

Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, 3624 DUMC, Baker House, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-018-2832-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999169PMC
July 2018

Recurrent Glioblastoma Treated with Recombinant Poliovirus.

N Engl J Med 2018 07 26;379(2):150-161. Epub 2018 Jun 26.

From the Departments of Neurosurgery (A.D., M.G., A.H.F., H.S.F., K.B.P., D.R., J.H.S., G.V., D.A., D.D.B.), Biostatistics (J.E.H., F.M.), Surgery (D.P.B., S.N.), and Pathology (W.T.H., R.E.M.) and the Preston Robert Tisch Brain Tumor Center (A.D., M.G., J.E.H., D.P.B., A.H.F., H.S.F., F.M., S.N., K.B.P., D.R., J.H.S., G.V., W.T.H., R.E.M., D.A., D.D.B.), Duke University Medical Center, and Istari Oncology (D.P.B.) - all in Durham, NC; Tempus Labs, Chicago (N.B.); and the School of Medicine, Deakin University, Geelong, VIC, Australia (A.M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716435DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065102PMC
July 2018

Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.

J Neurooncol 2018 Apr 21;137(2):349-356. Epub 2017 Dec 21.

Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2724-1DOI Listing
April 2018

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy.

Neuro Oncol 2018 01;20(2):249-258

Center for Neuro-Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts (P.Y.W, J.D.); The University of Texas MD Anderson Cancer Center, Houston, Texas (J.dG.); University of California, San Francisco, Helen Diller Cancer Center Building, San Francisco, California (M.D.P.); Duke University, Durham, North Carolina (D.A.R., A.D.); Neuro-Oncology Center, University of Virginia Health System, Charlottesville, Virginia (D.S.); University of Washington, Department of Neurology, Fred Hutchinson Cancer Research Center, Seattle, Washington (M.C.); Henry Ford Health System, Detroit, Michigan (T.M.); Exelixis, South San Francisco, California (J.H., J.P., R.W.); The Ronald Reagan UCLA Medical Center, Los Angeles, California (T.F.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777496PMC
January 2018

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.

Neuro Oncol 2018 01;20(2):259-267

The Ronald Reagan UCLA Medical Center, Los Angeles, California (T.F.C.); Center for Neuro-Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts (P.Y.W., J.D.); The University of Texas MD Anderson Cancer Center, Houston, Texas (J.dG.); University of California San Francisco, San Francisco, California (M.D.P.); Duke University, Durham, North Carolina (D.A.R., A.D.); Neuro-Oncology Center, University of Virginia Health System, Charlottesville, Virginia (D.S.); University of Washington, Department of Neurology, Fred Hutchinson Cancer Research Center, Seattle, Washington (M.C.); Henry Ford Health System, Detroit, Michigan (T.M.); Exelixis, South San Francisco, California (J.P., J.H., R.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777491PMC
January 2018

Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier.

Neuro Oncol 2016 06 17;18(6):840-8. Epub 2015 Dec 17.

University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov299DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864261PMC
June 2016

Vaccine Therapy, Oncolytic Viruses, and Gliomas.

Oncology (Williston Park) 2016 Mar;30(3):211-8

View Article

Download full-text PDF

Source
March 2016

CCR 20th Anniversary Commentary: Bevacizumab in the Treatment of Glioblastoma--The Progress and the Limitations.

Clin Cancer Res 2015 Oct;21(19):4248-50

Department of Hematology/Oncology, Saint Francis Hospital, Hartford, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1381DOI Listing
October 2015

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

J Clin Oncol 2015 Aug 13;33(24):2646-54. Epub 2015 Jul 13.

Giles W. Robinson, Brent A. Orr, Gang Wu, Tong Lin, Ibrahim Qaddoumi, Sue C. Kaste, Michael Rusch, Sariah J. Allen, Arzu Onar-Thomas, Clinton F. Stewart, James M. Boyett, Richard J. Gilbertson, David W. Ellison, and Amar Gajjar, St Jude Children's Research Hospital, Memphis, TN; Sridharan Gururangan and Annick Desjardins, Duke University Medical Center, Durham, NC; Roger J. Packer, Children's National Medical Center, Washington, DC; Stewart Goldman, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Michael D. Prados, University of California San Francisco, San Francisco, CA; Murali Chintagumpala, Texas Children's Cancer Center, Houston, TX; Naoko Takebe, National Cancer Institute, Bethesda, MD; Maryam Fouladi, Cincinnati Children's Hospital, Cincinnati, OH; and Tom Curran, Children's Hospital of Philadelphia, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.1591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534527PMC
August 2015

Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma?

Nat Rev Neurol 2015 Aug 21;11(8):429-30. Epub 2015 Jul 21.

The Preston Robert Tisch Brain Tumour Centre at Duke University Medical Centre, Department of Neurosurgery, DUMC Box 3624, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2015.127DOI Listing
August 2015

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.

Nature 2015 Mar 11;519(7543):366-9. Epub 2015 Mar 11.

1] Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina 27710, USA [2] Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA [3] Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA [4] Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710, USA [5] Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510871PMC
March 2015

Oncolytic polio virotherapy of cancer.

Cancer 2014 Nov 17;120(21):3277-86. Epub 2014 Jun 17.

Department of Surgery, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina; Division of Neurosurgery Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina; Department of Molecular Genetics and Microbiology, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.28862
Publisher Site
http://dx.doi.org/10.1002/cncr.28862DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205207PMC
November 2014

Bevacizumab therapy for glioblastoma: a passionate discussion.

CNS Oncol 2014 Jan;3(1):1-3

The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Room 047, Baker House, Trent Drive, DUMC 3624, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns.13.53DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128197PMC
January 2014

Imaging descriptors improve the predictive power of survival models for glioblastoma patients.

Neuro Oncol 2013 Oct 7;15(10):1389-94. Epub 2013 Feb 7.

Corresponding Author: Jordan Malof, PhD, Department of Electrical & Computer Engineering, Duke University, 130 Hudson Hall, Durham, NC 27708.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nos335DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779027PMC
October 2013

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.

Cancer Med 2013 Apr 24;2(2):185-95. Epub 2013 Jan 24.

Preston Robert Tisch Brain Tumor Center at Duke, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.58DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639657PMC
April 2013

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.

J Neurooncol 2012 Aug 26;109(1):63-70. Epub 2012 Apr 26.

Department of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0861-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404217PMC
August 2012

A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression.

J Neurooncol 2012 Apr 3;107(2):343-9. Epub 2011 Nov 3.

Princess Margaret Hospital, 610 University Avenue, Suite 18-717, Toronto, ON, M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0747-6DOI Listing
April 2012

Bevacizumab and daily temozolomide for recurrent glioblastoma.

Cancer 2012 Mar 26;118(5):1302-12. Epub 2011 Jul 26.

Department of Neurology, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26381DOI Listing
March 2012

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.

J Neurooncol 2012 Mar 11;107(1):155-64. Epub 2011 Oct 11.

Department of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0722-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616617PMC
March 2012

Neuro-oncology: Glioblastoma--community adjusts to new standard of care.

Nat Rev Neurol 2012 Mar 20;8(5):244-6. Epub 2012 Mar 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2012.42DOI Listing
March 2012

Avastin: more questions than answers. . .

J Neurosurg 2012 Feb 28;116(2):336-40; discussion 340. Epub 2011 Oct 28.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2011.8.JNS111107DOI Listing
February 2012

Everolimus tablets for patients with subependymal giant cell astrocytoma.

Expert Opin Pharmacother 2011 Oct 1;12(14):2265-9. Epub 2011 Aug 1.

Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Department of Surgery, Box 3624, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14656566.2011.60
Publisher Site
http://dx.doi.org/10.1517/14656566.2011.601742DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389821PMC
October 2011

Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapy.

J Neurooncol 2011 Jan 4;101(1):155-9. Epub 2010 Jun 4.

The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-010-0239-0DOI Listing
January 2011

A novel method for volumetric MRI response assessment of enhancing brain tumors.

PLoS One 2011 Jan 26;6(1):e16031. Epub 2011 Jan 26.

Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0016031PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027624PMC
January 2011

Bevacizumab fails to treat temporal paraganglioma: discussion and case illustration.

J Neurooncol 2010 Jul 19;98(3):427-30. Epub 2009 Dec 19.

Department of Surgery, Division of Neurosurgery, Duke University Medical Center, 220 Sands Building, Research Drive, Box 3050, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-009-0091-2DOI Listing
July 2010

Current available therapies and future directions in the treatment of malignant gliomas.

Biologics 2009 13;3:15-25. Epub 2009 Jul 13.

Preston Robert Tisch Brain Tumor Center; Department of Medicine, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726053PMC
February 2010

Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients.

J Neurooncol 2009 Oct 5;95(1):129-134. Epub 2009 May 5.

The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-009-9911-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837514PMC
October 2009

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.

Cancer 2009 Aug;115(15):3501-11

Department of Surgery, Duke University Medical Center, and The Preston Robert Tisch Brain Tumor Center, South Hospital, Durham, North Carolina. 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24398DOI Listing
August 2009

Repeatability of quantitative parameters derived from diffusion tensor imaging in patients with glioblastoma multiforme.

J Magn Reson Imaging 2009 May;29(5):1199-205

Duke University Medical Center, Department of Radiology, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.21732DOI Listing
May 2009

Experience with irinotecan for the treatment of malignant glioma.

Neuro Oncol 2009 Feb 10;11(1):80-91. Epub 2008 Sep 10.

The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://academic.oup.com/neuro-oncology/article/11/1/80/10504
Publisher Site
http://dx.doi.org/10.1215/15228517-2008-075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2718962PMC
February 2009

Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.

Expert Rev Anticancer Ther 2008 May;8(5):717-32

Division of Neurosurgery, Department of Surgery, Box 3050 Med Ctr, Preston Robert Tisch Brain Tumor Center at Duke University, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737140.8.5.717
Publisher Site
http://dx.doi.org/10.1586/14737140.8.5.717DOI Listing
May 2008

Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.

Expert Opin Biol Ther 2008 Apr;8(4):541-53

Duke University Medical Center, Neuro-Oncology Program, Department of Surgery, Division of Neurosurgery, 047 Baker House, Box 3624, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14712598.8.4.541
Publisher Site
http://dx.doi.org/10.1517/14712598.8.4.541 DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871667PMC
April 2008

The emerging role of anti-angiogenic therapy for malignant glioma.

Curr Treat Options Oncol 2008 Feb 7;9(1):1-22. Epub 2008 Feb 7.

Department of Surgery, Division of Neurosurgery, Duke University Medical Center, Box 3624, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-008-0052-6DOI Listing
February 2008

Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas.

Ther Clin Risk Manag 2007 Oct;3(5):707-15

The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center Durham, NC, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376068PMC
October 2007

Molecularly targeted therapy for malignant glioma.

Cancer 2007 Jul;110(1):13-24

The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22741DOI Listing
July 2007

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.

J Neurooncol 2007 May 24;83(1):53-60. Epub 2007 Jan 24.

Department of Medicine, Division of Neurology, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-006-9302-2DOI Listing
May 2007